COVID-19 vaccine

A team of researchers in Italy has claimed to develop a vaccine which can help them to contain coronavirus which causes COVID-19.

The breakthrough achieved by the scientists at Lazzaro Spallanzani National Institute for Infectious Diseases in Rome, as per reports.


The tests conducted on mice produced antibodies which work on human cells in blocking the virus from infecting people, reports says.

The development comes as scientists across the world are trying to develop vaccine to contain the menace. Scientists in US, Israel, Britain have gained significance progress as well.

Luigi Aurisicchio, CEO of Takis, the firm developing the medication, said that a coronavirus candidate vaccine has neutralised the virus in human cells for the first time, the Arab News reported.


“This is the most advanced stage of testing of a candidate vaccine created in Italy. Human tests are expected after this summer,” Aurisicchio was quoted as saying to Italian news agency ANSA.

As per tests conducted at Rome’s infectious-disease Spallanzani Hospital, the vaccine has antibodies generated in mice that work on human cells.

“As far as we know we are the first in the world so far to have demonstrated neutralisation of the coronavirus by a vaccine. We expect this to happen in humans too,” Aurisicchio added.

As per the COVID-19 Dashboard by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University, there are 3,664,011 coronavirus cases worldwide while the death toll has reached 257,301.


Be a part of Elets Collaborative Initiatives. Join Us for Upcoming Events and explore business opportunities. Like us on Facebook , connect with us on LinkedIn and follow us on Twitter , Instagram.

Related News


whatsapp--v1